Related Experiment Video
Updated: May 25, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Consensus guidelines for the management of plaque psoriasis
Sylvia Hsu1, Kim Alexander Papp, Mark G Lebwohl
1Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA. shsu@bcm.edu
Archives of Dermatology
|January 18, 2012
Summary
Updated Canadian guidelines for plaque psoriasis management now include new treatments like ustekinumab and excimer laser therapy. They also cover special patient populations and considerations for tumor necrosis factor blockers, surgery, and vaccinations.
Area of Science:
- Dermatology
- Clinical Guidelines
Background:
- Plaque psoriasis requires updated management strategies.
- New therapeutic agents and treatment modalities are available.
Purpose of the Study:
- To update the Canadian Guidelines for the Management of Plaque Psoriasis.
- To incorporate recent advancements and US-based treatment patterns.
Main Methods:
- Review of existing Canadian guidelines.
- Inclusion of newly approved agents (e.g., ustekinumab).
- Adaptation to reflect US practice patterns (e.g., excimer laser).
Main Results:
- Guidelines updated to include ustekinumab and excimer laser.
- Special populations addressed: children, pregnant patients, nursing mothers, elderly.
- Considerations for patients with viral infections (HBV, HCV, HIV), neoplasms, and elective surgery included.
Conclusions:
- Comprehensive update to plaque psoriasis management guidelines.
- Addresses diverse patient groups and emerging treatments.
- Provides current recommendations for clinical practice.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...